Dechra Pharmaceuticals

The AI engine Fit Assessment

Beta

The company will be attending the 2024 Health Tech Forward Event

Blurb

Dechra is a manufacturer of pharmaceutical products for veterinary use.

HQ Location

Northwich (United Kingdom)

Founded

1997

Employees

501 - 1000

Total funding raised

$5.60B

Funding Status

Acquired by EQT, June 2023

Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacturing, and sales of high-quality products exclusively for veterinarians worldwide. We are driven by our purpose of the sustainable improvement of local animal health and welfare.



Dechra has sales and marketing organizations in 26 countries and market our products in 63 other countries worldwide through distributors or marketing partners.



We see things from The Veterinary Perspective.



Dechra continues to grow because we understand the challenges veterinarians face, and provide training, support, and information to help them help animals. Accessible science enables vets to better communicate with their clients. It’s this perspective that makes us a preferred supplier. Understanding customers is built into our business model. We give veterinarians what they need, from everyday evidence-based treatments to knowledge on rarer diseases. To ensure our growth, we’re not just an animal pharma company. We’re the veterinary professional’s pharma company.



#TheVeterinaryPerspective



Learn more about our company at Dechra-US.com.